MARKET

DVHGF

DVHGF

DEVONIAN HEALTH GROUP INC
OTCMQB
0.071
NaN%
Closed 09:30 12/26 EST
OPEN
--
PREV CLOSE
0.071
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.180
52 WEEK LOW
0.071
MARKET CAP
11.80M
P/E (TTM)
-2.1743
1D
5D
1M
3M
1Y
5Y
1D
Devonian Health Group Grants Stock Options to Directors, Employees, and Consultant
Reuters · 12/19 14:15
Devonian Health Group Announces Grant of Stock Options
Barchart · 12/19 08:15
DEVONIAN HEALTH GROUP REPORTS FINANCIAL RESULTS OF ITS FIRST QUARTER ENDED ON OCTOBER 31, 2025 AND PROVIDES CORPORATE UPDATE
Reuters · 12/12 13:45
Devonian Health Group Inc. Releases 2025 Annual Report
Reuters · 12/04 16:58
Devonian Health Group Unveils Promising Anti-Inflammatory Results for Thykamine in New Study
Reuters · 12/04 13:45
Devonian Health Group Inc. posts FY net loss per share of CAD (0.041), widening 3.4 times
Reuters · 11/26 21:24
THEON INTERNATIONAL PLC - CONTRACT INCLUDES INITIAL ORDER OF 6,000 UNITS
Reuters · 11/26 17:01
DEVONIAN HEALTH GROUP REPORTS ITS FOURTH QUARTER AND ANNUAL 2025 FINANCIAL RESULTS AND APPOINTMENT OF A NEW BOARD MEMBER
Reuters · 11/26 17:01
More
About DVHGF
Devonian Health Group Inc. is a clinical-stage pharmaceutical company. It specializes in the development of drugs for various autoimmune inflammatory conditions with novel therapeutic approaches to targeting unmet medical needs. It is developing prescription drugs for the treatment of inflammatory autoimmune diseases, including but not limited to, ulcerative colitis and atopic dermatitis. It is also involved in the development of cosmeceutical products, leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health problems related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., sells prescription pharmaceutical products.

Webull offers Devonian Health Group Inc stock information, including OTCMQB: DVHGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVHGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DVHGF stock methods without spending real money on the virtual paper trading platform.